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Tbjective: Continuous infusion of warm to normothermic cardioplegia may limit the
urgeon’s visual field, increase coronary vascular resistance, and lead to potassium-
xacerbated ischemia-reperfusion damage. Our aim was to examine the versatility of
new normokalemic, nondepolarizing adenosine–lidocaine cardioplegia during
ontinuous or intermittent infusion at 33°C and compare it with lidocaine cardio-
legia.
ethods: Isolated, perfused rat hearts (n  6 each group) were arrested at 33°C for
0 or 60 minutes with 200 m of adenosine and 500 m of lidocaine in Krebs-
enseleit buffer (10 mmol/L glucose, pH 7.6-7.7 at 37°C) or 500 m of lidocaine
n Krebs–Henseleit buffer for 60 minutes delivered at 60 mm Hg.
esults: Times to arrest were 7 to 10 seconds for the adenosine–lidocaine groups
nd 102 seconds for the lidocaine group (P  .05). Total cardioplegia volumes for
ntermittent (2 minutes every 18 minutes) and continuous deliveries were 122 to 159
L and 699 to 922 mL for the 40- and 60-minute adenosine–lidocaine arrest
rotocols, respectively, and 136 mL for the 60-minute intermittent lidocaine group.
n the last 2 minutes of the 40- and 60-minute arrest protocols, the coronary vascular
esistance was not significantly different for the hearts arrested with adenosine and
idocaine (0.27–0.32 megadyne/sec/cm5). Significantly higher coronary vascular
esistance was found in the lidocaine cardioplegia group (0.38 megadyne/sec/cm5).
o significant differences were found between the continuous or intermittent
denosine–lidocaine delivery protocols. Hearts arrested with adenosine and lido-
aine recovered 88% to 89% of aortic flow and 109% of coronary flow at 60 minutes
f reperfusion after 40-minute arrest, and 77% to 86% of aortic flow and 98% to
09% of coronary flow at 60 minutes of reperfusion after 60-minute arrest. Lido-
aine cardioplegia led to significantly lower aortic and coronary flows after 60-
inute arrest compared with the intermittent adenosine–lidocaine group.
onclusions: We conclude that adenosine–lidocaine cardioplegia can be delivered
ntermittently or continuously with similar functional recoveries after a 40- or
0-minute arrest at 33°C. Hearts receiving lidocaine cardioplegia took a signifi-
antly longer time to arrest, showed higher coronary vascular resistance, and
chieved lower functional recovery than the 60-minute adenosine–lidocaine cardio-
legia groups. Intermittent or continuous delivery of adenosine–lidocaine cardio-
legia may offer an alternative to current surgical hyperkalemic cardioplegia at
arm to normothermic temperatures.
or more than 3 decades, hypothermia has been widely accepted as an
important component of myocardial protection during cardiac surgery.1 Tra-
ditionally, the main reason for selecting hypothermia has been to decrease
yocardial oxygen demand beyond the reduction achieved with electrochemical
rrest induced by high potassium concentrations. Oxygen consumption during arrest
t 11°C is 0.135 mL O2/min per 100 g myocardium (97% reduction from rest at
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CSP7°C) compared with 1.1 mL O2/min per 100 g myocardium
hen arrested at 37°C (90% reduction).2 Although hypo-
hermic arrest is still widely used, it has been increasingly
ssociated with myocardial ischemia and stunning.3-5 The
ypothermic heart, for example, is more susceptible to
rrhythmias during “reanimation” and often requires elec-
rical cardioversion to achieve normal sinus rhythm.5
In the early- to mid-1980s, Rosenkranz and associates6
nd Teoh and colleagues7 challenged the underlying prin-
iples of hypothermic arrest and showed that induction of
rrest with normothermic blood cardioplegia was superior
o cold blood cardioplegia in functional recovery in the
anine model. A few years later, Salerno and colleagues8
nd Lichtenstein and colleagues9,10 proposed warm heart
urgery with systemic normothermia as an alternative to
ypothermic methods. Studies investigating normothermia
ave reported improved tissue distribution of oxygen and
quivalence or improvement in postischemic functional out-
omes, including cognitive functions.5,11-14 Nondepolariz-
ng cardioplegia, using lidocaine alone as the arresting
gent, has also shown protective properties at normothermic
emperatures in animal models.15-17
Despite an increasing number of investigators advocat-
ng warm surgery, there remain legitimate concerns with
ardioplegic arrest at tepid to warm (33°C-37°C) heart
emperatures. One problem confronting surgeons is the fine
alance between the need to interrupt cardioplegia delivery
o perform surgery and the need to continuously infuse to
rotect the heart at these higher temperatures. Lichtenstein
nd others10 suggested that a reasonable margin of safety
xists if single interruptions are less than approximately
3 minutes. However, the safe period for intermittent
elivery and total crossclamp times have not been estab-
ished.5,10,12,18-20 In addition to obscuring the operating
eld, continuous delivery has been associated with
otassium-induced injury to myocytes and the coronary
asculature,21 increased vascular resistance with prolonged
rossclamp times leading to higher pump delivery pres-
ures,22-24 and postoperative left ventricular dysfunction.25
Accordingly, the aim of the present study was to examine
he efficacy of a new normokalemic, nondepolarizing car-
ioplegia delivered at 33°C using both continuous and in-
ermittent delivery protocols in the isolated working rat
eart. An arrest temperature of 33°C was chosen on the
asis of the studies of Engleman and colleagues26 and
uyton and colleagues,25 who reported that tepid tempera-
Abbreviations and Acronyms
AL  adenosine and lidocaine
CVR coronary vascular resistanceures provided optimal myocardial recovery and brain pro- 9
172 The Journal of Thoracic and Cardiovascular Surgery ● Maection during cardiac surgery. Previously we showed in the
at heart that a crystalloid formulation of adenosine and
idocaine (AL) cardioplegia conferred greater protection at
2°C to 29°C compared with St Thomas’ hospital number 2
olution delivered intermittently during 2 to 4 hours of
rrest.27 More recently we showed in the canine model of
ardiopulmonary bypass that functional recovery after in-
ermittent delivery of normothermic AL blood cardioplegia
as equivalent to hypothermic potassium arrest; however,
ontinuous delivery at normothermic temperatures was not
tudied.28 In the present study we report that AL cardiople-
ia can be delivered continuously or intermittently at 33°C
ith no significant differences in postarrest functional re-
overy. We also report that lidocaine only cardioplegia was
ot as effective as AL cardioplegia in the time to arrest,
aintenance of coronary artery vascular resistance, or func-
ional recovery during reperfusion.
aterials and Methods
nimals
ale Sprague–Dawley rats (370-450 g) from James Cook Univer-
ity’s breeding colony were fed ad libitum and housed in a 14:10-
our light:dark cycle. Rats were anesthetized with an intraperito-
eal injection of thiopentone sodium (100 mg/kg body weight),
nd hearts were rapidly excised.27 Rats were handled in compli-
nce with James Cook University Guidelines (Ethics Approval
umber A759) and the “Guide for Care and Use of Laboratory
nimals,” published by the National Institutes of Health (publica-
ion 85, revised 1985). Adenosine (A9251  99% purity) and
ther chemicals were obtained from Sigma Chemical Co (Castle
ill, NSW). Lignocaine hydrochloride (lidocaine) was purchased
s a 2% solution (ilium) from the local Pharmaceutical Supplies
Lyppard, Queensland).
omposition of Buffers and Arrest Solutions
Krebs–Henseleit perfusion buffer. Isolated rat hearts were
erfused in the Langendorff (nonworking) and working mode with
modified Krebs–Henseleit buffer containing 10 mmol/L glucose;
17 mmol/L NaCl, 5.9 mmol/L KCl, 25 mmol/L NaHCO3, 1.2
mol/L NaH2PO4, 1.12 mmol/L CaCl2 (free Ca2  1.07 mmol/L),
.512 mmol/L MgCl2 (free Mg2  0.5 mmol/L), pH 7.4 at
7°C.27 The perfusion buffer was filtered using a 1-m membrane
nd then bubbled vigorously with 95% O2/5% CO2 to achieve a
O2 greater than 600 mm Hg. The perfusion buffer was not
ecirculated.
Adenosine and lidocaine arrest solution. Adenosine (200
m) plus lidocaine (500 m) cardioplegia (AL) was freshly pre-
ared in normokalemic Krebs–Henseleit buffer containing 10
mol/L glucose at pH 7.7.27 The AL arrest solution was filtered
sing a 0.2-m filter and delivered at 33°C. The arrest solution
as not actively bubbled with 95% O2 and 5% CO2.
Lidocaine arrest solution. Lidocaine (500 m), in an other-
ise identical normokalemic Krebs–Henseleit buffer containing
0 mmol/L glucose, was filtered using a 0.2-m filter and main-
ained at 33°C. The arrest solution was not actively bubbled with
5% O2 and 5% CO2.
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CS
PAn adenosine control group was not included in this study
ecause adenosine in Krebs–Henseleit buffer at 200 m does not
aintain arrest in the isolated rat heart at 32°C to 33°C (n  2) or
t 22°C to 29°C (n  6) (unpublished data, Sloots, BSc [Hons],
006).
Isolated–perfused (Langendorff and working) rat heart
reparation. Hearts were rapidly removed from anesthetized rats
nd immediately placed in an ice-cold Krebs–Henseleit buffer.
xcess tissue was removed, and the heart was connected through
he aorta to a standard Langendorff apparatus and perfused in a
etrograde fashion with a perfusion pressure of 80 cm H2O (60 mm
g).27 The pulmonary artery was cannulated for collection of
oronary venous effluent. After tying off the pulmonary veins and
uperior and inferior vena cava to minimize leaks (1 mL/min),
he atrium was cannulated and the preparation was then switched
o working mode. The preload (inflow of buffer into the left
trium) was set at 10 cm H2O (7.6 mm Hg), and the afterload was
et at 100 cm H2O (76 mm Hg). Hearts were stabilized for 10
inutes before converting back to Langendorff (nonworking)
ode to administer the arrest solution. Heart rate, aortic pressure,
oronary flow, aortic flow, inflow and coronary venous oxygen
ontent, and oxygen consumption were measured before, during,
nd after arrest as reported previously.27 Rate–pressure product, an
ndex of oxygen demand,29 was calculated from the heart rate 
eak systolic pressure.
Aortic pressure was measured continuously using a pressure
ransducer (UFI Instruments, Morro Bay, Calif) coupled to a
acLab 2e (ADI Instruments, Sydney, Australia). Systolic and
iastolic pressures and heart rate were calculated from the pressure
race using MacLab software. Inflow and coronary venous perfus-
te PO2 and PCO2, pH, and ion concentrations (Ca2, Cl, K, and
a) were measured using a Bayer 865 blood gas analyzer (Bayer
iagnostics, Queensland, Australia). Coronary venous flow and
ortic flow were measured in volumetric cylinders. The initial
riteria for exclusion of working hearts during the 10-minute
quilibration period was a heart rate less than 250 beats/min,
ystolic pressure less than 110 mm Hg, and coronary flow less than
0 mL/min. No pacing or cardiac massage was used during the
ecovery phase in the working mode. The heart’s surface temper-
ture was measured during arrest using a Cole-Palmer Thermistor
hermometer (8402-20) (Cole-Palmer Instrument Co, Vernon
ills, Ill), which was tucked under the left auricle.
ode of Cardioplegic Delivery and Experimental
rotocol
ats were randomly assigned to 5 groups for delivery of cardio-
legia solution: (1) 40-minute arrest with continuous AL solution
n  6); (2) 40-minute arrest with intermittent AL solution (n 
); (3) 60-minute arrest with continuous AL solution (n  6); (4)
0-minute arrest with intermittent AL solution (n  6); (5) 60-
inute arrest with intermittent lidocaine cardioplegia (n  6).
urgical tepid temperature was maintained by placing a thermo-
tatically regulated water-perfused jacket around the heart when
equired to yield a heart surface temperature of 32°C to 33°C.
orty-minute Arrest Protocol
Continuous. The cardioplegia was administered through theorta at 33°C and a constant pressure of 60 mm Hg with the heart a
The Journal of Thoracicn the Langendorff mode for 40 minutes. At 18 and 38 minutes the
ardioplegia flow rate and volume were measured and used to
stimate coronary vascular resistance (CVR) during arrest.
Intermittent. A strategy of 20-minute intervals for delivery of
ardioplegia was used. A 50-mL induction dose of cardioplegia
olution was administered at 33°C, and the aorta was crossclamped
sing a plastic nontraumatic clip for 18 minutes. The clip was then
eleased to deliver a 2-minute infusion pulse of cardioplegia solu-
ion, and the clamp was reapplied. A terminal cardioplegia infu-
ion was given at 38 minutes for 2 minutes. The cardioplegia flow
ate and volume at 18 and 38 minutes were measured to estimate
VR.
ixty-minute Arrest Protocol
Continuous. The arrest solution was administered in Langen-
orff mode for 60 minutes per the 40-minute protocol, with car-
ioplegia volume measured at 18, 38, and 58 minutes of arrest.
Intermittent. A 50-mL induction dose was administered per
he 40-minute protocol, with 2-minute pulses of cardioplegia so-
ution at 18 and 38 minutes, and a terminal infusion for 2 minutes
fter 58 minutes of arrest. The cardioplegia volume at 18, 38, and
8 minutes was measured for estimating CVR.
After arrest, all hearts were switched to working mode and
eperfused with oxygenated Krebs–Henseleit buffer containing
lucose at 37°C, and the function was monitored for 1 hour of
eperfusion.
oronary Vascular Resistance
VR in megadynes/second/centimeters5 was calculated during
ardioplegia delivery by dividing delivery pressure (millimeters of
ercury) by flow (milliliters/second) from equation 1.
CVR
1333mm Hg
(ml ⁄ sec)  10
6 (1)
here 1 mm Hg  1333 dynes cm2 and 106 is a conversion
actor from dynes to megadynes.27
tatistical Analysis
ll results are expressed as mean  standard error of the mean.
ata from the 40- and 60-minute protocols were analyzed sepa-
ately. Two-way analysis of variance for repeated measures was
sed to compare discrete variables (eg, aortic flow, systolic pres-
ures) over multiple time points between the treatment groups,
ith a Bonferroni post hoc test to show where the differences
xisted.
esults
rrest Times, Cardioplegia Solution Volumes, and
oronary Vascular Resistance
rrest times are shown in Table 1. No significant differ-
nces were found between the different AL arrest protocols,
hich ranged from 7.2 0.8 seconds to 10.0 1.8 seconds
n  24). Hearts receiving lidocaine cardioplegia took
02  27 seconds to arrest (P  .01), with values ranging
rom 25 to 200 seconds (Table 1). In addition, ventricular
rrest occurred before atrial arrest in 2 hearts receiving
and Cardiovascular Surgery ● Volume 133, Number 5 1173
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1
CSPidocaine cardioplegia, and heart escape beats occurred for
minutes before full electrochemical arrest was achieved in
heart receiving lidocaine.
The total volume of cardioplegia solution delivered to
earts during the 40-minute arrest period was 699.4  0.5
L during continuous delivery and 121.5  0.6 mL during
ntermittent delivery (Table 1). For the 60-minute arrest
rotocol, the total cardioplegic volume was 922.1 0.3 mL
or continuous flow and 159.3  0.8 mL for intermittent
elivery. There was a slight (5%) decrease in AL cardio-
legia volume per minute delivered during the 40- and
0-minute arrest periods, but this was not significant. The
olume of lidocaine cardioplegia delivered per minute dur-
ng the 60-minute arrest period decreased significantly from
1.7  2.1 mL/min to 25.5  1.4 mL/min (P  .01).
CVRs are shown in Figure 1. At 18 minutes of arrest
here was no significant difference in CVR between the
ontinuous and the intermittent AL arrest groups (data not
hown), or at 38 minutes (0.28 0.01 megadyne/sec/cm5)
or both 40-minute arrest groups (Figure 1, A), or at 38
inutes for the two 60-minute AL arrest groups (0.32 
.01 vs 0.27  0.02 megadyne/sec/cm5 (Figure 1, A).
imilarly, there was no significant difference at 58 minutes
or the continuous and intermittent AL groups (0.32  0.01
egadyne/sec/cm5 vs 0.27  0.02 megadyne/sec/cm5,
espectively) (Figure 1, B). In contrast, CVR in the 60-
inute intermittent lidocaine group was significantly differ-
nt from the 60-minute intermittent AL group after 38
inutes of arrest (0.34  0.03 megadyne/sec/cm5) (P 
05) and during the terminal delivery of cardioplegia after
8 minutes of arrest (0.38  0.02 megadyne/sec/cm5)
P  .01) (Figure 1, B).
The time for the hearts to spontaneously recover electri-
al activity after arrest is shown in Table 1. There were no
ignificant differences between the AL groups or the lido-
aine group, although the time to achieve aortic flow varied
ABLE 1. Arrest time and delivered cardioplegia volumes
ontinuous or intermittent delivery of adenosine and lidoc
ardioplegia delivery
egimen
Arrest time
(sec)
Induction
volume
(mL)
Cardioplegia
volumes
(2 min at 18 min)
(mL)
L 40 min continuous 10.0 1.8 N/A 35.6 1.6
L 40 min intermittent 8.2 0.8 50 37.0 1.9
L 60 min continuous 8.0 0.4 N/A 31.7 1.4
L 60 min intermittent 7.2 0.8 50 37.3 2.2
idocaine 60 min
intermittent
102 27* 50 31.7 2.1
L, Adenosine and lidocaine; N/A, not available. For methods of the differen
ith all other groups. †P  .01 lidocaine group cardioplegia volume at 58
ardioplegia volume at 58 minutes compared with AL intermittent group crom 4.0  0.8 minutes for the AL 40-minute continuous a
174 The Journal of Thoracic and Cardiovascular Surgery ● Maroup to 11.7  2.7 minutes for the lidocaine 60-minute
ntermittent group. However, this difference was not signif-
cant because of the range in data within both the 60-minute
ntermittent AL and lidocaine groups (Table 1).
unctional Profiles Before Arrest and During
ecovery
uring the pre-arrest period there was no significant differ-
nce in the functional parameters measured among the 5
roups tested in the 40- and 60-minute arrest protocols
Tables 2 and 3). Heart rate, developed pressures, aortic
ow, coronary flow, and rate-pressure product during the
ecovery period for the 40-minute arrest groups are shown
n Table 2. Percentage recovery of aortic flow and coronary
ow during reperfusion are shown in Figure 2, A and B.
earts arrested with continuous AL for 40 minutes recov-
red 89% 6% of heart rate, 85% 5% of pre-arrest aortic
ow, and 100%  7% of pre-arrest coronary flow after 15
inutes of reperfusion. Hearts arrested with intermittent AL
or 40 minutes recovered 91%  4% of heart rate, 82% 
% of pre-arrest aortic flow, and 106%  10% of pre-arrest
oronary flow after 15 minutes of reperfusion. After 30
inutes of reperfusion, the flows had increased to a maxi-
um of 105%  7% of pre-arrest aortic flow and 108% 
% of pre-arrest coronary flow in the continuous group, and
4%  3% of pre-arrest aortic flow and 99%  3% of
re-arrest coronary flow in the intermittent group. There
as a subsequent slight decrease in aortic flows by 60
inutes of reperfusion, but there was no significant differ-
nce in heart rate, aortic flow, coronary flow, or rate-
ressure product between groups during the recovery
eriod.
Functional parameters during recovery in hearts arrested
or 60 minutes are shown in Table 3 and Figure 2, A and B.
y 15 minutes of reperfusion, heart rate recovered to
2%  4% and 88%  5% of pre-arrest values in hearts
g 40-minute or 60-minute arrest (Langendorff mode) using
or lidocaine only cardioplegia at 32°C to 33°C (n  6)
dioplegia
olumes
at 38 min)
(mL)
Cardioplegia
volumes
(2 min at 58 min)
(mL)
Total
cardioplegia
volume (mL)
Time to
first beat
(min)
Time to
aortic flow
(min)
.3  1.2 N/A 699.4 0.5 1.7 0.6 4.0  0.8
.5  1.7 N/A 121.5 0.6 1.8 0.5 7.5  1.3
.7  1.1 30.0 1.0 922.1 0.3 2.5 0.2 6.1  0.7
.0  2.1 35.3 2.4 159.3 0.8 3.5 0.6 10.0  2.0
.0  2.1 25.5 1.4† 136.1 0.7 3.3 1.3 11.7  2.7
veries see “Materials and Methods.” *P  .01 lidocaine group arrest time
es compared with 18 minutes (paired-samples t test), and lidocaine group
plegia volume at 58 minutes.durin
aine
Car
v
(2 min
34
34
30
37
29
t deli
minutrrested with AL continuous and AL intermittent methods,
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CS
Pespectively, and 68%  11% of pre-arrest value in hearts
rrested with lidocaine. There were no significant differ-
nces between these groups in heart rate or rate-pressure
roduct during the recovery period. After 15 minutes of
eperfusion, hearts arrested with AL solution had recovered
7%  4% of pre-arrest aortic flow and 98%  5% of
re-arrest coronary flow in the continuous group and 77%
% of pre-arrest aortic flow and 104%  8% of pre-arrest
oronary flow in the intermittent group, compared with
4%  12% recovery of aortic flow and 75%  15%
ecovery of coronary flow in the lidocaine group. There was
significant difference in recovery of aortic flow between
igure 1. CVR measured after 38-minute arrest (A) and 58-minute
rrest (B) in hearts arrested for 40 or 60 minutes with continuous
r intermittent delivery of AL or lidocaine cardioplegia. (*P < .05
idocaine group compared with AL intermittent group after 38-
inute arrest; **P < .01 lidocaine group compared with AL
ntermittent group after 58-minute arrest.) For the method of CVR
alculation, see “Materials and Methods.” AL, Adenosine and
idocaine; CVR, coronary vascular resistance; Cont, continuous;
nt, intermittent.he 60-minute intermittent lidocaine arrest group and the c
The Journal of Thoracic0-minute intermittent AL arrest group (P  .01) and AL
ontinuous group (P .05). Recovery of coronary flow was
lso significantly different between the intermittent lido-
aine group and the AL intermittent group (P  .01).
When data from AL groups were compared, there was a
rend in the intermittent group toward increased coronary
ow and lower CVR during arrest, and improved recovery
f aortic flow and coronary flow during the recovery period
ompared with the continuous group, but these differences
id not reach statistical significance.
iscussion
lthough hypothermic cardioplegia seems to remain the
ost popular method of myocardial protection,1,23,30 the use
f tepid and warm cardioplegia is increasingly being inves-
igated to establish the safe temperature and optimal proce-
ure for protecting the heart and brain during cardiac sur-
ery.13,24,28,31,32 The main goal of the present study was to
nvestigate the effect of intermittent delivery of a new
ormokalemic, nondepolarizing AL cardioplegia at 33°C
nd compare the results with continuous delivery in the
solated rat heart model. On the basis of functional out-
omes (CVR, aortic flow, coronary flow, systolic and dia-
tolic pressures, and heart rate), we report that protection of
he myocardium and coronary vasculature seems to be
quivalent with intermittent and continuous infusion of AL
ardioplegia during 40 minutes and 60 minutes of arrest at
3°C. We further report that intermittent delivery of lido-
aine cardioplegia was not as effective as intermittent AL
ardioplegia. The presence of adenosine with lidocaine led
o faster arrest times and conferred greater protection during
nd after cardioplegic arrest.
arm Intermittent Versus Warm Continuous Delivery
he present study demonstrated that intermittent AL car-
ioplegia was equivalent to continuous AL cardioplegia,
espite the fact that total cardioplegia volume for the inter-
ittent group was less than 20% of the continuous infusion
roup (Table 1). This shows that greater cardioplegia volume
oes not improve outcome in this model. In addition, there
as no significant difference in CVR between the intermit-
ent and continuous AL groups, with values ranging from
.27  0.02 megadyne/sec/cm5 to 0.32  0.02 megadyne/
ec/cm5 (Figure 1, A and B). Changes in CVR may be
elated to autoregulation (smooth muscle constriction or
elaxation), extravascular compression (caused by systolic
nd diastolic mechanics and tissue edema), or particulate
mbolization in the microvessels. A relatively constant
VR indicates that there were no differences in smooth
uscle reactivity, vascular endothelial function, or ex-
ravascular compression from edema during 40 or 60 min-
tes of global ischemic arrest between the AL groups. In
ontrast, in pigs undergoing cardiopulmonary bypass, Eric-
and Cardiovascular Surgery ● Volume 133, Number 5 1175
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1
CSPson and colleagues23 demonstrated that CVR increased 1.7
imes from approximately 0.33 mm Hg/min/mL1 at 5
inutes to 0.55 mm Hg/min/mL1 at 45 minutes; they
uggested that this increase may have been linked to in-
reased endothelial dysfunction or perivascular edema as-
ociated with warm continuous hyperkalemic cardioplegia.
e did not test vascular reactivity for endothelial function
nd therefore cannot comment on potential differences in
ndothelial function between the groups. Using a canine
odel, Torchiana and colleagues24 demonstrated that CVR
ncreased slowly to a maximum of 2.5-fold in the last
inute of receiving antegrade warm hyperkalemic blood
ABLE 2. Functional parameters of isolated rat hearts durin
r intermittent delivery of adenosine and lidocaine cardio
rrest protocol
40-minute
cardioplegia
delivery regimen
Heart rate
(beats/min)
Syst
pres
(mm
re-arrest Continuous 297 18 140.8
Intermittent 313 16 136.7
eperfusion 15 min Continuous 263 20 140.0
Intermittent 282 11 133.3
eperfusion 30 min Continuous 281 15 137.5
Intermittent 321 14 127.5
eperfusion 45 min Continuous 300 17 133.3
Intermittent 325 12 126.7
eperfusion 60 min Continuous 306 13 133.3
Intermittent 322 8 127.5
ABLE 3. Functional parameters of isolated rat hearts durin
r intermittent delivery of adenosine and lidocaine or lido
n  6)
rrest protocol
60-minute
cardioplegia
delivery regimen
Heart
rate
(beats/min)
S
p
(
re-arrest AL continuous 309 10 126
AL intermittent 317 14 140
Lidocaine intermittent 339 16 134
eperfusion 15 min AL continuous 254 17 126
AL intermittent 276 12 135
Lidocaine intermittent 226 34 124
eperfusion 30 min AL continuous 288 14 122
AL intermittent 304 6 132
Lidocaine intermittent 293 17 127
eperfusion 45 min AL continuous 297 18 120
AL intermittent 310 10 132
Lidocaine intermittent 290 13 126
eperfusion 60 min AL continuous 297 16 119
AL intermittent 317 12 132
Lidocaine intermittent 302 13 124
L, Adenosine and lidocaine. *Significant difference in aortic flow between
L continuous group (P  .05). †Significant difference in coronary flow between
176 The Journal of Thoracic and Cardiovascular Surgery ● Maardioplegia. They and others further postulated that the
ncreased CVR was likely caused by the depolarizing po-
assium in the cardioplegia, an observation previously noted
y Kucich in 1987,22 and that this effect of potassium may
e more pronounced at higher temperatures.33,34 Further-
ore, in 1991 Mankad and colleagues21 reported that high
otassium levels in St Thomas’ hospital solution or
retschneider solution resulted in endothelial damage and
hat this deleterious effect of potassium was concentration
ependent. Increased CVR during arrest from hyperkalemia
ay also compromise the distribution of the cardioplegic
olution and increase the risk of ischemic injury.23 For
e-arrest and reperfusion (working mode), using continuous
ia for 40-minute arrest at 32°C to 33°C (n  6)
Diastolic
pressure
(mm Hg)
Aortic flow
(mL/min)
Coronary
flow
(mL/min)
Rate pressure
product
(mm Hg/min)
65.0 3.4 60.3 0.5 20.8 1.2 41,733  2339
63.3 2.1 57.7 2.9 19.2 1.0 42,700  1835
65.0 2.6 51.3 2.9 20.8 1.9 36,600  2623
61.7 4.0 47.8 3.9 20.0 1.5 37,425  1799
65.8 3.3 53.8 1.1 22.3 1.2 38,513  1713
63.3 4.0 54.0 1.9 19.0 1.3 40,783  2013
65.0 3.4 54.2 0.4 23.2 1.2 39,913  1940
65.0 5.0 52.8 1.8 21.0 1.7 41,021  1658
65.0 3.4 53.3 0.7 22.7 0.9 40,729  1594
66.0 4.9 51.0 1.7 20.7 0.9 40,958  1607
e-arrest and reperfusion (working mode), using continuous
e only cardioplegia for 60-minute arrest at 32°C to 33°C
ic
re
g)
Diastolic
pressure
(mm Hg)
Aortic
flow
(mL/min)
Coronary
flow
(mL/min)
Rate pressure
product
(mm Hg/min)
3.6 71.7 4.0 56.7 1.6 20.7 0.8 39,025  892
3.9 75.0 3.2 61.0 2.4 21.3 1.7 44,275  2155
2.7 70.0 2.2 51.7 0.8 19.8 1.4 45,413  1949
4.2 72.5 4.4 44.0 3.1 20.3 1.7 31,875  1295
3.4 75.8 2.7 46.8 4.3 22.2 2.3 37,292  2124
14.0 70.0 5.0 27.5 6.2 14.2 2.8 30,327  5526
4.6 74.2 4.0 47.8 2.5 20.7 1.1 34,938  966
3.6 76.7 2.5 54.3 2.1 20.7 1.1 40,271  1179
1.7 72.5 3.1 37.2 2.5 16.2 0.9 37,329  2242
4.5 73.3 4.4 46.3 2.7 21.0 1.8 35,496  1331
4.2 75.8 3.3 53.5 2.0 22.8 1.2 40,929  1041
1.7 71.7 2.8 37.5 1.9 16.3 0.9 36,817  2042
4.4 73.3 4.4 43.5 3.6 20.5 1.9 35,008  826
4.2 76.7 2.5 52.6 1.9 23.0 1.1 41,854  1538
1.5 70.8 2.7 36.3 2.2* 16.8 0.7† 37,513  1946
aine intermittent group compared with AL intermittent group (P .01) andg pr
pleg
olic
sure
Hg)
 0.8
 3.1
 2.2
 6.3
 2.1
 5.3
 2.5
 5.1
 2.5g pr
cain
ystol
ressu
mm H
.7
.0
.2
.7
.0
.3
.5
.5
.5
.8
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.2
lidoc
lidocaine intermittent group compared with AL intermittent group (P  .01).
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CS
Pany decades, high depolarizing potassium concentrations
ave been used in aortic ring studies and artery conduits to
nduce maximum vasoconstriction response when studying
he effect of new drugs on coronary vasoreactivity.35 AL
ardioplegia may offer an alternative to the possible detri-
ental effects of high depolarizing potassium concentration
n the microvasculature because potassium is kept at nor-
al plasma values.27
After global ischemic arrest, our study also showed that
here were no significant differences in functional recovery
fter 40- and 60-minute arrest with AL (Tables 2 and 3). For
xample, hearts arrested for 60 minutes with intermittent or
ontinuous AL recovered similar percentages of pre-arrest
alues in developed pressures, heart rate, aortic flow, coro-
igure 2. Percentage of pre-arrest values of (A) aortic flow and
B) coronary flow recorded during the 60-minute reperfusion
eriod in hearts arrested with: 40 minutes of continuous AL, □:
0 minutes of intermittent AL, x: 60 minutes of continuous AL, :
0 minutes of intermittent AL, and : 60 minutes of intermittent
idocaine. *Significant difference in aortic flow between the
0-minute intermittent lidocaine group compared with 60-minute
L intermittent group (P < .01) and 60-minute AL continuous
roup (P < .05), and *significant difference in coronary flow
etween the 60-minute intermittent lidocaine group compared
ith 60-minute AL intermittent group (P < .01).ary flow, and rate-pressure product after 60 minutes of v
The Journal of Thoraciceperfusion (Table 3). These data suggest that the myocar-
ium and coronary microvasculature were protected during
he 40- or 60-minute arrest period using AL cardioplegia at
3°C. Although there was a trend for intermittent delivery
f AL cardioplegia to improve functional recovery after 60
inutes of arrest, these differences were not significant.
arm Intermittent Adenosine–Lidocaine Cardioplegia
ersus Lidocaine Cardioplegia
ntermittent AL cardioplegia was also compared with inter-
ittent lidocaine cardioplegia over a 60-minute arrest at
3°C. In this study, intermittent lidocaine cardioplegia was
ot as effective as intermittent AL cardioplegia, with vari-
ble and significantly longer arrest times (102 27 seconds
s 7.2  0.8 to 10.0  1.8 seconds) (Table 1), significantly
igher CVR during arrest (20% higher CVR measured at
8 and 58 minutes) (Figure 1, B), and significantly lower
eturns in aortic and coronary flows during reperfusion (P
01) (Table 3). Lidocaine cardioplegia has been advocated
s an alternative to K depolarizing cardioplegia by a
umber of groups using Langendorff perfused rat and rabbit
earts.15-17 Although lidocaine at 500 m arrests the rat
eart faster than does clamping a heart receiving Krebs–
enseleit alone (1.7  0.45 vs 10.7  2.2 minutes (n  4,
npublished data, Sloots, BSc [Hons], 2006), the key is to
nclude 200 m of adenosine, which arrests the heart faster
nd confers greater protection on the myocardium and cor-
nary vasculature compared with lidocaine only cardiople-
ia (Figure 1, B; Table 3).
onclusions
n the past, surgeons have been reluctant to adopt warm cardiac
urgery presumably because of the effects of near-continuous
elivery of depolarizing potassium cardioplegia on the heart
nd the potential deleterious effects of higher temperatures on
rain function.5,10,19,20 In addition, there seems to be a lack of
onsensus concerning the safe period for interrupting the flow
f cardioplegia to visualize the operative field and the length of
rossclamp time.5,10,19,20 The possible clinical significance of
eveloping nondepolarizing AL cardioplegia may relate to (1)
educing the need for high depolarizing potassium in cardio-
legia; (2) offering the surgeon greater versatility over the
isual field at higher temperatures; (3) providing lower CVR
nd greater uniformity of cardioplegia delivery to the myocar-
ium; (4) protecting the myocardium and coronary vasculature
rom ischemic injury36-38; (5) providing greater control over
he patient’s serum K levels and other related electrolytes,
articularly in those patients with renal disease; and (6) having
he benefits of potent anti-inflammatory properties.18,39,40 Al-
hough we acknowledge the strengths and limitations of using
he perfused rat heart model and crystalloid cardioplegia in this
tudy,41 further large animal studies and human safety trials are
equired to examine AL cardioplegia as an alternative to con-
entional K-based cardioplegia practices.
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